Australia Dementia Treatment Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$129.7

Forecast, 2030 (US$M)

$244.9

CAGR, 2024 - 2030

9.5%

Report Coverage

Australia

Australia dementia treatment market, 2018-2030 (US$M)

Related Markets

Global Dementia Treatment Industry

North America Dementia Treatment Market Outlook

U.S. Dementia Treatment Market Outlook

Canada Dementia Treatment Market Outlook

Europe Dementia Treatment Market Outlook

Germany Dementia Treatment Market Outlook

France Dementia Treatment Market Outlook

Italy Dementia Treatment Market Outlook

Spain Dementia Treatment Market Outlook

Denmark Dementia Treatment Market Outlook

Sweden Dementia Treatment Market Outlook

Norway Dementia Treatment Market Outlook

UK Dementia Treatment Market Outlook

Asia Pacific Dementia Treatment Market Outlook

Japan Dementia Treatment Market Outlook

China Dementia Treatment Market Outlook

India Dementia Treatment Market Outlook

South Korea Dementia Treatment Market Outlook

Thailand Dementia Treatment Market Outlook

Latin America Dementia Treatment Market Outlook

Mexico Dementia Treatment Market Outlook

Argentina Dementia Treatment Market Outlook

Brazil Dementia Treatment Market Outlook

MEA Dementia Treatment Market Outlook

South Africa Dementia Treatment Market Outlook

Saudi Arabia Dementia Treatment Market Outlook

UAE Dementia Treatment Market Outlook

Kuwait Dementia Treatment Market Outlook

Australia dementia treatment market highlights

The Australia dementia treatment market generated a revenue of USD 129.7 million in 2023 and is expected to reach USD 244.9 million by 2030.
The Australia market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
In terms of segment, alzheimer’s disease dementia was the largest revenue generating indication in 2023.
Lewy Body Dementia is the most lucrative indication segment registering the fastest growth during the forecast period.

Dementia treatment market data book summary

Market revenue in 2023	USD 129.7 million
Market revenue in 2030	USD 244.9 million
Growth rate	9.5% (CAGR from 2023 to 2030)
Largest segment	Alzheimer’s disease dementia
Fastest growing segment	Lewy Body Dementia
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia, Other Indications
Key market players worldwide	Eisai Co Ltd, Eli Lilly and Co, Novartis AG ADR, Daiichi Sankyo Co Ltd, AbbVie Inc, H. Lundbeck AS Class A, Biogen Inc, Cipla Ltd DR, Sun Pharmaceutical Industries, Viatris Inc

Other key industry trends

In terms of revenue, Australia accounted for 0.8% of the global dementia treatment market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China dementia treatment market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 904.6 million by 2030.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Dementia Treatment Market Scope

Dementia treatment market segmentation & scope

Dementia Treatment Market Companies

Name	Profile	# Employees	HQ	Website

Australia dementia treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dementia treatment market will help companies and investors design strategic landscapes.

Alzheimer’s disease dementia was the largest segment with a revenue share of 60.06% in 2023. Horizon Databook has segmented the Australia dementia treatment market based on alzheimer’s disease dementia, vascular dementia, lewy body dementia, frontotemporal dementia (ftd), parkinson disease dementia, other indications covering the revenue growth of each sub-segment from 2018 to 2030.

Australia Dementia Treatment Indication Outlook (Revenue, USD Million, 2018-2030)
- Alzheimer’s Disease Dementia
- Vascular Dementia
- Lewy Body Dementia
- Frontotemporal Dementia (FTD)
- Parkinson Disease Dementia
- Other Indications
Australia Dementia Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Cholinesterase Inhibitors
- NMDA Receptor Antagonist
- MAO Inhibitors
- Combination Drug
- Other Drug Classes
Australia Dementia Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Transdermal Patch
- Injectable
Australia Dementia Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

Reasons to subscribe to Australia dementia treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia dementia treatment market databook

Our clientele includes a mix of dementia treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia dementia treatment market, including forecasts for subscribers. This country databook contains high-level insights into Australia dementia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.